A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Sara E. Kochanny, Francis P. Worden, Douglas R. Adkins, Dean W. Lim, Julie E. Bauman, Stephanie A. Wagner, Ryan J. Brisson, Theodore G. Karrison, Walter M. Stadler, Everett E. Vokes, Tanguy Y. Seiwert
Dive into the research topics of 'A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma'. Together they form a unique fingerprint.